ZA968054B - Therapeutic use of hemoglobin in promoting wound healing - Google Patents

Therapeutic use of hemoglobin in promoting wound healing

Info

Publication number
ZA968054B
ZA968054B ZA968054A ZA968054A ZA968054B ZA 968054 B ZA968054 B ZA 968054B ZA 968054 A ZA968054 A ZA 968054A ZA 968054 A ZA968054 A ZA 968054A ZA 968054 B ZA968054 B ZA 968054B
Authority
ZA
South Africa
Prior art keywords
hemoglobin
wound healing
therapeutic use
promoting wound
promoting
Prior art date
Application number
ZA968054A
Other languages
English (en)
Inventor
Kenneth E Burhop
Ari K Leppaniemi
Diana S Malcolm
Raluan Soltero
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of ZA968054B publication Critical patent/ZA968054B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA968054A 1995-10-26 1996-09-25 Therapeutic use of hemoglobin in promoting wound healing ZA968054B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54866795A 1995-10-26 1995-10-26

Publications (1)

Publication Number Publication Date
ZA968054B true ZA968054B (en) 1997-05-02

Family

ID=24189867

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA968054A ZA968054B (en) 1995-10-26 1996-09-25 Therapeutic use of hemoglobin in promoting wound healing

Country Status (8)

Country Link
EP (1) EP0862440B1 (fr)
JP (1) JPH11513709A (fr)
AU (1) AU6779996A (fr)
CA (1) CA2235548A1 (fr)
DE (1) DE69627367T2 (fr)
NO (1) NO981866L (fr)
WO (1) WO1997015313A1 (fr)
ZA (1) ZA968054B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10031741A1 (de) * 2000-06-29 2002-01-17 Sanguibio Tech Ag Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel
DE10212321A1 (de) * 2002-03-20 2003-10-09 Sanguibio Tech Ag Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden
JP2006188440A (ja) * 2004-12-28 2006-07-20 Tokai Univ 創傷治癒促進剤
US20080241208A1 (en) * 2005-06-30 2008-10-02 Charles Shanley Methods, Compositions and Devices For Promoting Anglogenesis
EP2550973B1 (fr) 2011-07-23 2013-08-28 SastoMed GmbH Pulvérisateur pour plaies
EP2614833A1 (fr) 2012-01-13 2013-07-17 SastoMed GmbH Traitement de plaies avec réduction de cicatrices
US10729748B2 (en) 2012-01-13 2020-08-04 Mölnlycke Health Care Ab Scarring reducing wound treatment
CN104547584A (zh) * 2015-01-13 2015-04-29 陈琦 一种促进刨宫产手术后切口愈合的中药喷剂及制备方法
EP3421044A1 (fr) 2017-06-26 2019-01-02 SastoMed GmbH Transporteurs d'oxygène pour le traitement des affections bénignes de la peau

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001200A (en) * 1975-02-27 1977-01-04 Alza Corporation Novel polymerized, cross-linked, stromal-free hemoglobin
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4053590A (en) * 1975-02-27 1977-10-11 Alza Corporation Compositions of matter comprising macromolecular hemoglobin
US4405606A (en) * 1981-05-04 1983-09-20 Evreka, Inc. Method for arresting fulminating infection
US5464814A (en) * 1986-06-20 1995-11-07 Northfield Laboratories, Inc. Acellular red blood cell substitute
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion

Also Published As

Publication number Publication date
EP0862440A4 (fr) 2000-04-12
DE69627367T2 (de) 2004-02-12
AU6779996A (en) 1997-05-15
NO981866D0 (no) 1998-04-24
EP0862440B1 (fr) 2003-04-09
CA2235548A1 (fr) 1997-05-01
EP0862440A1 (fr) 1998-09-09
NO981866L (no) 1998-06-25
WO1997015313A1 (fr) 1997-05-01
JPH11513709A (ja) 1999-11-24
DE69627367D1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
US5401504B1 (en) Use of tumeric in wound healing
HU9602583D0 (en) Gel for treatment of skin diseases and for disinfection of the skin
HK1015280A1 (en) Use of epinastine in the treatment of pain
IL113399A0 (en) Human bone stimulating factor
ZA969217B (en) Skin care preparation and method
PL312718A1 (en) Competitors and opponents of human interleukine-10
HK1022269A1 (en) Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections
HK1001375A1 (en) Use of acetylsalicylic acid in the manufacture of a drug for the treatment of skin injuries
GB9523335D0 (en) Improvements in or relating to skin treatment materials
ZA968054B (en) Therapeutic use of hemoglobin in promoting wound healing
HUP9904294A3 (en) Topiramate derivatives and their use for producing medicament useful in the treatment of neuropathic pain
PL336760A1 (en) Treatment of skin diseases
ZA952519B (en) Therapeutic use of hemoglobin in the treatment of blood vessel blockage
ZA967915B (en) Therapeutic administration of hemoglobin in cardiac arrest
AU6968098A (en) Topical treatment of skin diseases and eye afflictions
ZA938898B (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
AU4661797A (en) Therapeutic use of hemoglobin to treat head injury
ZA9610584B (en) Use of rc-9 in diagnosis and treatment of proliferative arterial disease
GB9523066D0 (en) Compounds and their therapeutic use
ZA951440B (en) Novel opiold peptides for the treatment of pain and use thereof
AUPM808194A0 (en) Therapeutic treatment and preparation
GB9312780D0 (en) Therapeutic and cosmetic treatment
SI0814813T1 (en) Use of penciclovir for the treatment of human herpes-virus-8
GB9614034D0 (en) Treatment of wounds